Cape Haven Bio
New Haven, US · 1 known investors
Cape Haven Bio is a venture creation firm focused on translating early-stage academic discoveries into commercially viable biotech companies developing therapeutics. The firm provides strategic planning, lab infrastructure, seed capital, and consulting resources to support the progression from research to investable business.
Investors · 1
Competitors · 2
by search overlap
Biohaven4 shared keywordsBiohaven is a pharmaceutical company that discovers, develops, and commercializes medications for neurological and neuropsychiatric diseases, including epilepsy, pain, mood disorders, OCD, spinocerebellar ataxia, and spinal muscular atrophy. The company operates as a modern publicly traded entity and was acquired by Pfizer in May 2022 for approximately $13 billion.
AdvanceCT4 shared keywordsAdvanceCT is a nonprofit economic development organization that drives job creation and capital investment in Connecticut through business attraction, retention, and expansion. It works with state and local partners to support inclusive business development and provide companies with resources, workforce solutions, and research.
Companies competing with Cape Haven Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cape Haven Bio do?
- Cape Haven Bio is a venture creation firm focused on translating early-stage academic discoveries into commercially viable biotech companies developing therapeutics. The firm provides strategic planning, lab infrastructure, seed capital, and consulting resources to support the progression from research to investable business.
- Who are Cape Haven Bio's investors?
- Cape Haven Bio's investors include Connecticut Innovations.
- Where is Cape Haven Bio headquartered?
- Cape Haven Bio is headquartered in New Haven, US.